A detailed history of Argent Trust CO transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Argent Trust CO holds 1,091 shares of MEDP stock, worth $373,874. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,091
Previous 1,191 8.4%
Holding current value
$373,874
Previous $490,000 25.92%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$320.58 - $457.29 $32,058 - $45,729
-100 Reduced 8.4%
1,091 $363,000
Q2 2024

Aug 12, 2024

BUY
$372.0 - $424.34 $6,696 - $7,638
18 Added 1.53%
1,191 $490,000
Q1 2024

May 10, 2024

SELL
$284.87 - $413.31 $93,152 - $135,152
-327 Reduced 21.8%
1,173 $474,000
Q3 2023

Nov 08, 2023

SELL
$233.98 - $281.67 $215,495 - $259,418
-921 Reduced 38.04%
1,500 $363,000
Q2 2023

Aug 11, 2023

BUY
$187.26 - $240.17 $453,356 - $581,451
2,421 New
2,421 $581,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.7B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Argent Trust CO Portfolio

Follow Argent Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Argent Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Argent Trust CO with notifications on news.